{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:20:23Z","timestamp":1792160423792,"version":"4.4.0"},"reference-count":71,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Advances in Wound Care"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Sickle-cell leg ulcers (SCLUs) are a severe, chronic, and recurrent complication of sickle-cell disease (SCD). There are no official recommendations for treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Advances:<\/jats:title>\n                    <jats:p>Only a few studies with a high level of evidence have been conducted to evaluate treatment of SCLUs. However, several studies have been conducted with a high level of evidence to evaluate the efficacy of treatments in venous leg ulcers, and SCLUs could benefit from these treatments, especially when a venous incompetence or an edema is associated. Pathophysiology of SCLUs includes a vasculopathy related to chronic hemolysis and an endothelial dysfunction, which could be therapeutic approaches to SCLU treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Critical Issues:<\/jats:title>\n                    <jats:p>Therapeutic approaches to SCLUs can target SCD on the one hand and skin healing and associated aggravating factors on the other. A review of the literature found only case series and six randomized controlled trials; some offered encouraging results, but most had serious biases. Clinical trials specifically targeting SCLUs are difficult to realize because of the small number of affected patients, in comparison with patients with leg ulcers from other causes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Future Direction:<\/jats:title>\n                    <jats:p>Treating SCLUs remains a challenge. Data in the literature are currently insufficient to offer clear treatment guidelines because of several biases in controlled studies. New studies are under way to assess the efficacy of topical treatments and describe the microbiome of SCLUs. Prevention of SCLU recurrence should be assessed in future clinical trials because the high risk of recurrence is an unsolved critical issue.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/wound.2018.0918","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T11:19:53Z","timestamp":1556104793000},"page":"348-356","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":43,"title":["Leg Ulcers in Sickle-Cell Disease: Treatment Update"],"prefix":"10.1177","volume":"9","author":[{"given":"Jean-Beno\u00eet","family":"Monfort","sequence":"first","affiliation":[{"name":"Department of Dermatology, Tenon Hospital, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Senet","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tenon Hospital, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000189089.45003.52"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005565"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70404-4"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07115.x"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21838"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.4.1403.1403"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-755777"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61029-X"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.068965"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-268193"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2015.11.005"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15241"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12570"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1067-1927.2004.012207.x"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24134"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(14)00019-2"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.12496"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12522"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.1096"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830290203"},{"key":"e_1_3_4_22_2","article-title":"Zinc supplements for treating thalassaemia and sickle cell disease","volume":"6","author":"Swe KM","year":"2013","unstructured":"Swe KM, , Abas AB, , Bhardwaj A, , Barua A, , Nair NS. Zinc supplements for treating thalassaemia and sickle cell disease. Cochrane Database Syst Rev, 2013; 6:CD009415.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(70)92067-2"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/jan.13474"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03833.x"},{"key":"e_1_3_4_26_2","article-title":"Compression for preventing recurrence of venous ulcers","volume":"9","author":"Nelson EA","year":"2014","unstructured":"Nelson EA, , Bell-Syer SE. Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev, 2014; 9:CD002303.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000265.pub3"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62368-5"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16353-8"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39216.542442.BE"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2014.04.059"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801214"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.40.10.1187"},{"key":"e_1_3_4_34_2","first-page":"121","article-title":"A randomized controlled trial of solcoseryl and duoderm in chronic sickle-cell ulcers","volume":"42","author":"La Grenade L","year":"1993","unstructured":"La Grenade L, , Thomas PW, , Serjeant GR. A randomized controlled trial of solcoseryl and duoderm in chronic sickle-cell ulcers. West Indian Med J, 1993; 42:121\u2013123.","journal-title":"West Indian Med J"},{"key":"e_1_3_4_35_2","first-page":"1775","article-title":"Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix","volume":"84","author":"Wethers DL","year":"1994","unstructured":"Wethers DL, , Ramirez GM, , Koshy M, et al. Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group. Blood, 1994; 84:1775\u20131779.","journal-title":"RGD Study Group. Blood"},{"key":"e_1_3_4_36_2","article-title":"Interventions for treating leg ulcers in people with sickle cell disease","volume":"12","author":"Mart\u00ed-Carvajal AJ","year":"2014","unstructured":"Mart\u00ed-Carvajal AJ, , Knight-Madden JM, , Martinez-Zapata MJ. Interventions for treating leg ulcers in people with sickle cell disease. Cochrane Database Syst Rev, 2014; 12:CD008394.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(87)90049-6"},{"key":"e_1_3_4_38_2","first-page":"108","article-title":"Role of nitric oxide, nitroxidative and oxidative stress in wound healing","volume":"57","author":"Soneja A","year":"2005","unstructured":"Soneja A, , Drews M, , Malinski T. Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacol Rep, 2005; 57 Suppl:108\u2013119.","journal-title":"Pharmacol Rep"},{"key":"e_1_3_4_39_2","first-page":"298","article-title":"The use of bovine collagen-glycosaminoglycan matrix for atypical lower extremity ulcers","volume":"28","author":"Garwood CS","year":"2016","unstructured":"Garwood CS, , Kim PJ, , Matai V, et al. The use of bovine collagen-glycosaminoglycan matrix for atypical lower extremity ulcers. Wounds, 2016; 28:298\u2013305.","journal-title":"Wounds"},{"key":"e_1_3_4_40_2","first-page":"866","article-title":"Rapid healing of sickle cell leg ulcers treated with collagen dressing","volume":"81","author":"Reindorf CA","year":"1989","unstructured":"Reindorf CA, , Walker-Jones D, , Adekile AD, , Lawal O, , Oluwole SF. Rapid healing of sickle cell leg ulcers treated with collagen dressing. J Natl Med Assoc, 1989; 81:866\u2013868.","journal-title":"J Natl Med Assoc"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12217"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20063"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000076487"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08395.x"},{"key":"e_1_3_4_45_2","first-page":"164","article-title":"Isoxsuprine hydrochloride in the therapy of sickle cell leg ulceration","volume":"26","author":"Serjeant GR","year":"1977","unstructured":"Serjeant GR, , Howard C. Isoxsuprine hydrochloride in the therapy of sickle cell leg ulceration. West Indian Med J, 1977; 26:164\u2013166.","journal-title":"West Indian Med J"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(18)30758-8"},{"key":"e_1_3_4_47_2","first-page":"32","article-title":"Evaluation of clinical response by hydroxyurea in 132 patients with major sickle cell anemia [In French]","volume":"83","author":"Dokekias EA","year":"2005","unstructured":"Dokekias EA, , Okandze Elenga JP, , Ndinga J, , Sanogo I, , Sangare A. Evaluation of clinical response by hydroxyurea in 132 patients with major sickle cell anemia [In French]. Tunis Med, 2005; 83:32\u201337.","journal-title":"Tunis Med"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221333"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-12-200806170-00221"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-12-200806170-00220"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.56.7.1722-1729.1988"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1990.tb04768.x"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07206.x"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00129334-200410000-00010"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1159\/000204799"},{"key":"e_1_3_4_56_2","first-page":"157","article-title":"Treatment of chronic sickle cell leg ulcers with supplemental oxygen","volume":"165","author":"Barnes SC.","year":"2013","unstructured":"Barnes SC. Treatment of chronic sickle cell leg ulcers with supplemental oxygen. J La State Med Soc, 2013; 165:157\u2013158.","journal-title":"J La State Med Soc"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-475X.2008.00436.x"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004123.pub4"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(86)70154-0"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.12467"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-018-0887-0"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122561"},{"key":"e_1_3_4_63_2","first-page":"10","article-title":"The management of leg ulcers in sickle cell anaemia","volume":"16","author":"Walshe MM","year":"1967","unstructured":"Walshe MM, , Milner PF. The management of leg ulcers in sickle cell anaemia. West Indian Med J, 1967; 16:10\u201316.","journal-title":"West Indian Med J"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14326"},{"key":"e_1_3_4_65_2","first-page":"293","article-title":"Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent","volume":"134","author":"Falanga V","year":"1998","unstructured":"Falanga V, , Margolis D, , Alvarez O, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol, 1998; 134:293\u2013300.","journal-title":"Human Skin Equivalent Investigators Group. Arch Dermatol"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.02003.x"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1177\/1534734614534979"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1177\/1534734616685636"},{"key":"e_1_3_4_69_2","article-title":"Negative pressure wound therapy for treating leg ulcers","volume":"7","author":"Dumville JC","year":"2015","unstructured":"Dumville JC, , Land L, , Evans D, , Peinemann F. Negative pressure wound therapy for treating leg ulcers. Cochrane Database Syst Rev, 2015; 7:CD011354.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_70_2","first-page":"62","article-title":"Negative pressure therapy for complex wounds in patients with sickle-cell disease: a case study","volume":"56","author":"Oliveira Paggiaro A","year":"2010","unstructured":"Oliveira Paggiaro A, , Fernandes de Carvalho V, , Hencklain Fonseca GH, , Doi A, , Castro Ferreira M. Negative pressure therapy for complex wounds in patients with sickle-cell disease: a case study. Ostomy Wound Manage, 2010; 56:62\u201367.","journal-title":"Ostomy Wound Manage"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2006.07.030"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12389"}],"container-title":["Advances in Wound Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/wound.2018.0918","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/wound.2018.0918","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/wound.2018.0918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:22:17Z","timestamp":1773238937000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/wound.2018.0918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,8]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1089\/wound.2018.0918"],"URL":"https:\/\/doi.org\/10.1089\/wound.2018.0918","relation":{},"ISSN":["2162-1918","2162-1934"],"issn-type":[{"value":"2162-1918","type":"print"},{"value":"2162-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,8]]}}}